from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1134/-

LFCtreatmentdescriptionclass of inhibitor

-0.556

Amikacinug/mL Amikacintranslation

-0.375

Cap5-10ug/mL Capreomycintranslation

-0.455

Rox10-50 ug/mL Roxithromycintranslation

-0.624

SM2-5 ug/mL Streptomycintranslation

-0.346

Tet5-10 ug/mL Tetracyclinetranslation

-0.473

Rif0.2-5ug/mL Rifampicintranscription

-0.461

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.976

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.744

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.161

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.426

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.350

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.498

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.430

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.048

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.445

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.163

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.855

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.726

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.226

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.637

KCN5-20 ug/mL Potassium cyaniderespiration

0.122

NaN30.2-2 mM Sodium aziderespiration

-0.901

Nigericin50 uM Nigericinrespiration

0.348

TRC10-150 ug/mL Triclosanrespiration

0.212

TRZ10-25 ug/mL Thioridazinerespiration

-0.179

Valinomycin0.5-10 uM Valinomycinrespiration

2.022

ZnSO42 mM ZnSO4respiration

0.604

menadione6-10 ug/mL Menadionerespiration

0.692

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.493

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.334

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.932

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.195

NRP_1Non-replicating persistence stage 1dosRassociated

-0.644

Amp0.2mg/mL AmpicillincellWall

-0.448

Cephalexin20-100 ug/mL CephalexincellWall

-0.377

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.835

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.709

EMB10-20 ug/mL EthambutolcellWall

-1.356

Eta12-40 ug/mL EthionamidecellWall

-1.523

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.602

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.237

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.450

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.144

BZA0.12 mg/mL BenzamidearomaticAmides

0.430

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.242

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.765

H2O24 mM hydrogen peroxideDNAdamaging

-0.215

Levo10 ug/mL LevofloxacinDNAdamaging

0.320

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.264

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.887

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.214

UVUV-irradiationDNAdamaging

-0.164

ARP41-4 ug/mL Antitubercular compound ARP4?

0.371

Antimycin12.5-50 ug/mL Antimycin A?

-0.535

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.348

PA_110-50 ug/mL Antitubercular compound PA-1?

1.232

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.893

PA8240.2-2 ug/mL PA-824?

0.171

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.331

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.002

Verapamil50 uM Verapamil?

0.120

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.947

methoxatin10-20 ug/mL Methoxatin?